Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04732676

Efficacy of a Smartphone App. Designed to Manage Craving & Individual Predictors of Substance Use/Addictive Behavior

Efficacy of a Smartphone App Designed to Manage Craving and Individual Predictors of Substance Use / Addictive Behavior Among Individuals With Addictive Disorders

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
274 (estimated)
Sponsor
Centre Hospitalier Charles Perrens, Bordeaux · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Test the Efficacy of a smartphone application designed to manage craving and individual predictors of substance use / addictive behavior among individuals with addictive disorders

Detailed description

This translational project is the clinical application of research results from the University of Bordeaux, Sanpsy Lab, CNRS USR3413 - on individual predictors of substance use. This project will test the efficacy of a smartphone application to help subjects concerned about reducing or stopping their substance use / behavioral addiction. This new therapeutic tool, designed by University of Bordeaux, Sanpsy Lab, CNRS USR3413 - to manage craving and individual predictors of use, will offer the possibility of an easy to-use and personalized intervention accessible to the greatest number of subjects. Based on our previous results that supports that, for all types of addiction, craving and individual cues are a significant drive for use in people with addiction, the application tested in this study was designed to be used among people presenting various types of addiction (substance and behavioral addictions). The application will also evaluate all concurrent substance uses and addictive behaviors to identify and prevent risk of addiction transfers.

Conditions

Interventions

TypeNameDescription
OTHERSmartphone applicationEcological Momentary Assessment (EMA) : ambulatory assessment of behaviors/symptoms in real-time on smartphones

Timeline

Start date
2023-03-01
Primary completion
2027-12-31
Completion
2028-07-31
First posted
2021-02-01
Last updated
2025-08-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04732676. Inclusion in this directory is not an endorsement.